5
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Patent Evaluation: Novel tricyclic quinoxalinediones as strychnine insensitive glycine antagonists

Pages 1391-1392 | Published online: 03 Mar 2008

REFERENCES

  • JOHNSON JW, ASHER P: Nature (1987) 385: 529-531.
  • MCBRAIN CJ, KLECKNER NW, WYIUCK S. DINGLEDINE R: MoL PharmacoL (1989) 36: 556-565.
  • HOOD WF, COMPTON RP, MONAHAN JB: Neurosc. Let. (1989) 98: 91-95.
  • LEESON DL, BAKER R, CARLING RW, CURTIS NR, MOORE KW, WILLIAMS BJ, FOSTER AC, DONALD AE, KEMP JA, MARSHALL OR: J. Med. Chem. (1991) 34: 1243-1252.
  • HUETTNER JE: Science (1989) 245: 1611-1613.
  • WATJEN F, NIELSEN EO, DREIER J, JENSEN LH: Bioorg. Med. Chem. Let. (1993) 3: 105-106.
  • LESTER RAJ, QUARUM ML, PARKER JD, WEBER E, JAHR CE: Mol. Pharm. (1989) 35: 565-570.
  • SHEARDOWN MJ NIELSEN EO, HANSEN AJ, JACOBSEN P, HONORE T: Science (1990) 247: 571-572.
  • KAWASAKI S, YATSUGI SI, TAKAHASHI M, KATOH M, KASHIYA K, SAKAMOTO S: Jpn. J. Phar-macoL (1993) 61(Suppl 1): 284P.
  • RANDLE JCR, GUET T, BOBICHON C, MOREAU C, CURUTCHET P. LAMBOLEZ B, PRADO DE CARVALHO L, CORD: A, LEPAGNOL 3M: Mol. Pharmacol. (1992) 41: 337-345.
  • Novo NORDISK AS, US5166155.
  • ELI LILLY & Co, US5153196.
  • Novo NoRriisx AS, W09306103-A1.
  • ELI LILLY & Co, US5196421.
  • SANDOZ LTD, EP-488959-A2.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.